U.S. Markets open in 61 hrs, 25 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 8,280.74 | -223.32 | -2.63% |
| NASDAQ | 1,796.52 | -49.20 | -2.67% |
| S&P 500 | 896.42 | -26.91 | -2.91% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 54.31 09:38 AM EDT | |
|---|---|---|
| Day High | 55.14 09:30 AM EDT |
|
| Range | 0.83 |
| Volume | 2.43 M | |
|---|---|---|
| 30-Day Avg Vol | 3.28 M |
|
| Difference | -25.83% |
| Market Cap | 14.76 B | |
|---|---|---|
| Mkt Cap Chg | -180.74 M |
| Shares Out | 269.76 M | |
|---|---|---|
| % Shrs Traded | 0.90% | |
| 1yr EPS Est | 3.418 |
| 52-Wk Low | 50.05 3/3/09 | |
|---|---|---|
| 52-Wk High | 83.97 8/18/08 |
|
| Range | 33.92 |
| Prev Close | 55.42 7/1/09 | |
|---|---|---|
| Today's Open | 54.92 | |
| Change | -0.90% |
| Dividend (TTM) | — | |
|---|---|---|
| Div Yield (TTM) | — | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 6.56 M |
| Revenue (LFY) | 2.20 B | |
|---|---|---|
| Earnings (LFY) | 86.53 M | |
| Earnings (MRQ) | 123.63 M | |
| Next Earn Est | 0.847 | |
| Next Earnings | 10/19/2009 |
|
| EPS (TTM) | 0.57 | |
| 1yr EPS Growth | -11.91% |
| P/E Ratio (TTM) | 32.59 | |
|---|---|---|
| P/E Ratio (Fwd) | 16.00 | |
| PEG Ratio | 0.72 | |
| Return on Equity | 2.49 | |
| Beta | 0.32 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Genzyme makes big money off small-time diseases. The company's product portfolio focuses on rare genetic disorders as well as kidney disease, cancer, and biosurgery. One of its main products, Cerezyme, ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | 0.847 7/22/09 | — — |
—
—
|
| Last Quarter | 1.049 3/31/09 | 0.82 3/31/09 |
-0.229
Missed
|
| 2 Quarters Ago | 1.024 12/31/08 | 1.04 12/31/08 |
0.016
Beat
|
| Quarterly - 06/30/2005 | Annual - 2004 | |
|---|---|---|
| Total Revenue | 668.14 M | 2.20 B |
| Gross Profit | 522.89 M | 1.50 B |
| Operating Income | 164.67 M | 514.00 M |
| Net Income | 123.63 M | 86.53 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts